Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0096
+0.0006 (6.67%)
Dec 26, 2024, 12:16 PM EST
Evofem Biosciences Company Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.
Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Evofem Biosciences, Inc. is headquartered in San Diego, California.
Evofem Biosciences, Inc.
Country | United States |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 38 |
CEO | Saundra Pelletier |
Contact Details
Address: 7770 Regents Roas San Diego, Delaware 92122 United States | |
Phone | 858 550 1900 |
Website | evofem.com |
Stock Details
Ticker Symbol | EVFM |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US30048L2034 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Saundra Pelletier | Interim Chair, President and Chief Executive Officer |
Ivy Zhang CPA | Chief Financial Officer and Secretary |
Amy Raskopf | Chief Business Development Officer and Senior Vice President of Investor Relations |
Ellen Thomas | Chief of Staff |
Kathy Gallo-Doyle | Senior Vice President of Commercial Operations |